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Abstract Poly(glycerol sebacate)-methacrylate (PGS-M) is a 
photocurable form of polyglycerol sebacate (PGS) that has re-
cently been shown to be suitable for use as a scaffold for tissue 
engineering. It has the benefits of PGS, including biocompatibil-
ity and biodegradability, while also being much simpler to pro-
cess into a variety of 3D structures. Cell compatibility has already 
been demonstrated on the 30% methacrylated PGS-M scaffolds. 
However no studies have yet assessed the collagen produced by 
cells growing on the PGS-M scaffold. Here we demonstrate that 
50% methacrylated PGS-M 3D scaffolds are able to support the 
culture of human dermal fibroblasts for 1 week. We also show 
that collagen production is enhanced compared with the same 
cells growing on tissue culture plastic, with the cells producing 
approximately 50% more total collagen after 1 week in culture. 
These results go further to demonstrate the suitability of the 
PGS-M scaffolds for generating ECM based constructs for soft 
tissue engineering. 
Index Terms tissue engineering, collagen, scaffold, fibroblasts, 
3D cell culture, soft tissue 
I. INTRODUCTION 
The extracellular matrix (ECM) is the non-cellular, 3D 
scaffold found in all tissues. In addition to providing the struc-
ture within which the cells grow, it plays important roles in cell 
differentiation, cell-cell communication, homeostasis and mor-
phogenesis [1]. The main fibrous proteins components of the 
ECM are collagen and elastin, with collagen making up ~30% 
of the total protein mass of a human [2]. Collagen provides the 
tensile strength for the tissue, while also controlling cell-matrix 
adhesion, chemotaxis and tissue development [3]. 
ECM scaffolds derived from decellularized mammalian tis-
sues have been used to generate tissue engineered constructs 
for tissue repair, and have already shown success in both pre-
clinical and clinical studies. These scaffolds appear to have 
benefits over synthetic scaffolds, including improved biological 
compatibility, reduced encapsulation and the potential for in 
vivo remodeling and an improvement in tissue regeneration [4±
7]. Furthermore, if the ECM is derived from the same type of 
tissue that it is being used to repair, it will possess the correct 
tissue architecture. However, this process still requires a source 
of tissue; there are limited donor supplies of the appropriate 
cadaveric human tissue, while xenogeneic ECM carries poten-
tial disease risks and ethical concern. The ECM used in this 
way is often derived from porcine small intestine submucosa 
(SIS). Although widely used in tissue engineering research [8] 
and the clinic for both wound management [8,9] and the repair 
of multiple tissue types [10±12], SIS has poor mechanical 
properties that may limit its usefulness.  
More recently there has also been interest in generating 
ECM scaffolds in the laboratory through the culture of human 
smooth muscle cells or fibroblasts on biodegradable synthetic 
scaffolds in vitro. The cells produce the ECM as the synthetic 
scaffold degrades. After an extended culture period the sample 
is decellularized, leaving behind an ECM-based scaffold with 
the same morphology as the original synthetic scaffold. This 
process has been used to generate off-the-shelf vascular grafts 
with mechanical properties similar to native human blood ves-
sels [6,13]. The collagen structure and organization within 
these scaffolds has also been further enhanced by applying 
mechanical loading to the cells during culture [14]. This re-
quires a synthetic scaffold with a degradation rate in the order 
of 8 to 10 weeks, which is also sufficiently elastic to effectively 
transduce the mechanical strain to the cells growing on the 
scaffold. Previous studies have used a polyglycolic acid scaf-
fold, however there are currently no reported studies which aim 
to optimize the synthetic scaffold for collagen production. 
We have recently reported a photocurable form of 
poly(glycerol sebacate) (PGS) with improved processing capa-
bilities for use in soft tissue engineering applications: PGS-
methacrylate (PGS-M)10. In this form, PGS is methacrylated 
resulting in a prepolymer which is photocurable in combination 
with a photoinitiator and light at the appropriate wavelength 
[15]. The properties of the PGS-M scaffold are tunable by 
varying the extent of methacrylation, and thus there is the po-
tential to optimize collagen production by changing the me-
chanical characteristics of the scaffold. 
Here we describe the growth of dermal fibroblasts on a 
50% methacrylated PGS-M scaffold and investigate the impact 
of the scaffold on production of collagen. 
II. MATERIALS AND METHODS 
All chemical reagents were obtained from Sigma Aldrich, 
UK, unless otherwise stated. 
A. Synthesis of PGS-M Scaffold 
The PGS-M prepolymer was synthesized following the pro-
tocol described by Pashneh-Tala et al. [15]. Briefly, PGS pre-
polymer was formed using the melt-polycondensation reaction 
(120°C, under nitrogen gas, 24h) using equimolar amounts of 
sebacic acid and glycerol (Fisher Scientific, UK). Water was 
removed under vacuum and the reaction allowed to continue 
for 36 h. The prepolymer was dissolved in a 1:4 (w/v) mixture 
of dichloromethane (Fisher Scientific, UK) and methacrylic 
anhydride (0.5 mol/mol PGS hydroxyl groups). An equimolar 
amount of triethylamine was then slowly added, followed by 4-
methoxyphenol (1 mg/g of PGS prepolymer). The reaction was 
performed at 0°C and allowed to rise to room temperature over 
24 h. The resulting solution was then washed with 30 mM hy-
drochloric acid (Fisher scientific, UK) at 1:1 (v/v), dried with 
calcium chloride (Fisher scientific, UK) and the dichloro-
methane removed via rotary evaporation, under vacuum. 
The PGS-M prepolymer was mixed with toluene and Hy-
permerTM B246 at 10:10:1 (w/w) ratio, before being mixed with 
photoinitiator diphenyl(2,4,6-trimethylbenzoyl)phosphine ox-
ide/2-hydroxy2-methylpropiophenone, blend, 0.4 g/g PGS pre-
polymer). After 5 minutes mixing, water was added (8 ml/g 
PGS prepolymer), to increase scaffold permeability and porosi-
ty [16]. The solution was poured into a PDMS 
(poly(dimethylsiloxane)) mold (3.5 cm (l) x 1.5 cm (w) x 0.2 
cm (d)) (Fig. 1A) and exposed to UV light (100W, OmniCure 
Series 1000 curing lamp) for 5 minutes on each side to photo-
cure. 
The scaffold produced (Fig. 1B) was washed in methanol 
then dH2O, each for 4 days, with solvents refreshed daily to 
remove uncured prepolymer and photoinitiator. The scaffold 
was then autoclaved (121°C, 15 minutes) in dH2O to sterilize, 
and stored at room temperature prior to use. 
B. Culture of cells on scaffolds 
Human dermal fibroblasts from primary dermal tissue were 
obtained with informed consent (REC 15/YH/0177) and pro-
cessed and stored in accordance with the Human Tissue Act 
2004. Fibroblasts were cultured in DulEHFFR¶V PRGLILHG (D
JOH¶VPHGLXP'0(0VXSSOHPHQWHGZLWKYYIHWDOFDOI
serum, 2 x 10-3 M glutamine, 100 IU ml-1 penicillin, 100 µg ml-
1
 streptomycin and 0.625 µg ml-1 amphotericin B. Cultured 
fibroblasts were harvested using trypsin (0.025%)/EDTA 
(0.01%) solution, and 1 x 105 cells seeded in each well of a 6 
well plate, or on sterile PGS-M scaffolds. Scaffolds were seed-
ed using very small volumes of cells (<20 µl) which were 
placed onto the scaffold and allowed to adhere at 37°C for one 
hour, before the scaffolds were fully submerged in culture me-
dia. Cells were then allowed to grow for 1 week at 37°C, 5% 
CO2, in a humidified atmosphere. After 24 hours cells were 
supplemented with 50 µg/ml ascorbic acid 2 phosphate, except 
where indicated. Scaffolds were cultured for 1 week, with the 
culture medium replaced every 2-3 days. Control experiments 
were also set up with cells growing in 6 well tissue culture 
plastic (TCP) plates. 
At the end of the experiment, scaffolds were transferred to 
fresh 6 well plates. Scaffolds or cells growing on TCP were 
either analyzed for cell metabolic activity via the MTT assay, 
or collagen content via the Sirius red assay. 
C. MTT Assay 
Scaffolds or cells growing on TCP were washed with PBS 
and incubated with MTT-ESTA (0.5 mg mL-1 in PBS) for 70 
minutes at 37°C. Acidified isopropanol (200 µL) was used to 
solubilize the formazan and absorbance was measured at 540 
nm with a protein reference of 630 nm subtracted. Activity was 
calculated as a percentage of the control. 
D. Sirius Red Assay 
Scaffolds or cells growing on TCP were washed with PBS 
and fixed with 4% formaldehyde for 20 min, before being 
washed 3x in PBS. Total cellular collagen production was 
quantified by staining with a 0.1% Picrosirius red solution 
(0.1% Direct Red 80 in saturated picric acid) for 18 hours at 
room temperature. The remaining solution was washed away 
with deionized water and the resulting stain was removed by 
rocking at room temperature with methanol:0.2 M sodium hy-
droxide (1:1) for 30 minutes. The absorbance of the resulting 
solution was then measured at 490 nm  
III. RESULTS 
The synthetic process used in this study was able to gener-
ate PGS-M scaffolds of the desired dimensions (Figure 1B). 
These scaffolds could then be sterilized and used to support 
fibroblast growth. Cell metabolic activity assays showed that 
viable human dermal fibroblasts could be observed  on the 50% 
methacrylated PGS-M scaffolds after 1 week in culture (Fig. 
2A), demonstrating the biocompatibility of the PGS-M scaf-
fold. However the metabolic activity measured at the end of the 
week was significantly lower (P=0.0005) than that observed for 
the same cells growing on the TCP control. However, interest-
ingly, Figure 2B shows that the cells growing on the PGS-M 
scaffolds generated approximately 50 % more total collagen 
over the course of the week in culture compared to the same 
cells on the TCP control (P<0.0001).  
Taking into account the reduced cell numbers on the PGS-
M scaffolds compared to the control it can be seen that there is 
an approximately 10 fold increase in the amount of collagen 
produced by the cells (Fig. 2C) when grown on the PGS-M 
scaffolds compared to the TCP control (P<0.0001). 
 
Fig. 1.  The PDMS mold (A) used to form the PGS-M prepolymer during 
the photocuring step, and the PGS-M scaffold (B) generated from 
this process 
The initial experiments were supplemented with ascorbic 
acid 2 phosphate in the culture medium. However, once it had 
been established that the fibroblasts produced significantly 
more collagen on the scaffolds than in 2D culture, further stud-
ies were performed to ascertain if the addition of ascorbic acid 
2 phosphate was in any way beneficial. Figure 3 shows the cell 
metabolic activity and total collagen from dermal fibroblasts 
after 1 week in culture on TCP or PGS-M scaffolds in the ab-
sence or presence of 50 µg ml-1 ascorbate acid-2-phosphate. 
The results show a similar response to that observed in the ini-
tial experiments, with a significant reduction in metabolic ac-
tivity and a significant increase in total collagen on the scaf-
folds compared to tissue culture plastic. However, removal of 
the ascorbic acid had no significant impact on collagen produc-
tion or cell proliferation in either 2D or 3D culture. 
IV. DISCUSSION 
Glass coverslips coated with a low Mw 30 % PGS-M film 
and 3D scaffolds with the same 30% methacrylation have pre-
viously been shown to support both fibroblast and smooth 
muscle cell growth at comparable levels to uncoated glass sur-
faces [15]. However, this is the first time that fibroblast growth 
on 50 % methacrylated PGS-M scaffolds has been reported. 
Although the metabolic activity of the cells growing on these 
scaffolds, as measured by the MTT assay, shows a significant 
decrease in activity compared to the TCP control. This suggests 
fewer cells growing on the scaffold than on TCP after 1 week.  
It has been noted that the responsiveness of the MTT assay 
appears to be greatly reduced when measuring cell metabolic 
activity in PGS-M scaffolds. Other methods to evaluate cell 
metabolic activity may be more suitable, such as the resazurin 
cell viability assay [17]; alternatively improved cell prolifera-
tion data may be more readily obtained through the quantifica-
tion of total DNA present [18]. However, it was also noted that 
many cells did not attach to the scaffold, with a large number 
of cells observed growing instead on the TCP around the scaf-
fold during the experiments. This reduced cell attachment is, in 
part at least, likely to have led to a reduction in cell numbers 
after 1 week in culture. Further studies are therefore required to 
determine whether the observed reduction in cell attachment on 
the scaffolds was a result of the change in the extent of methac-
rylation, or another factor, such as the cell seeding process, 
which may have resulted in cells being washed onto the TCP 
before cell attachment to the scaffold could take place.  
Despite the indication of reduced cell numbers growing in 
the PGS-M scaffolds, the total amount of collagen produced 
was significantly higher than for the cells growing on TCP. 
Other studies report similar findings, with an increase in colla-
gen production when cells are grown on other 3D scaffolds 
compared to 2D [19,20]. In particular, the non-methacrylated 
version of this scaffold, PGS, has already been shown to en-
hance collagen production [21,22], compared to cells grown in 
2D. This is perhaps unsurprising, since 3D scaffolds would be 
expected to facilitate growth of fibroblasts in a more biologi-
cally relevant environment, where the cells are better able to 
perform their normal functions of matrix formation and remod-
eling [23]. The PGS-M scaffold used in this study has similar 
properties to the PGS scaffold, being both biocompatible and 
biodegradable, but has the added advantage that it is simple to 
synthesize and can be readily photocured to generate a variety 
of 3D structures [15]. The additional evidence, generated in 
this study, that collagen production is also enhanced indicates 
that PGS-M shows considerable potential for use in soft tissue 
engineering. 
It was, however, unexpected that removal of ascorbic acid-
2-phosphate had no apparent effect on the culture. Ascorbic 
acid-2-phosphate is the stable version of Vitamin C, and is 
generally used in cell cultures to enhance collagen production, 
with around 2 to 3 fold increases in collagen production report-
ed from fibroblasts grown in similar concentrations of ascorbic 
acid [20,24,25]. Furthermore, other studies demonstrate that the 
addition of ascorbic acid-2-phosphate also increased fibroblast 
proliferation alongside enhanced collagen production [26,27]. 
The reports however do suggest that the optimal concentration 
of ascorbic acid-2-phosphate is cell type dependent; further-
more since the cells used in this study were primary cells, it 
may be that there is some patient to patient variability in the 
response to ascorbic acid-2-phosphate and consequently further 
optimization of concentrations may be required.  
It has also been shown that the application of mechanical 
strain during culture can enhance collagen production and or-
 
Fig. 2.  The cellular metabolic activity (A) and total collagen (B) detected 
after 1 week of human dermal fibroblast culture on TCP or 50% 
PGS-M scaffold. The ratio of total collagen to metabolic activity is 
also shown (C). Results shown are mean from n=3 samples, error 
bars are standard deviation.  
 
Fig. 3.  The impact of removing the ascorbic acid-2-phosphate 
supplement (AA) from the culture medium upon cell metabolic 
activity (A) and collagen production (B) when cells are culture for 1 
week on TCP or 50% PGS-M scaffolds. Results shown are mean 
from n=3 samples, error bars are standard deviation.  
ganization in engineered tissues [28,29]. Therefore, the effect 
of mechanical stimulation of the PGS-M scaffolds on both cell 
proliferation and collagen production will be assessed in future 
experiments to determine if the increase in collagen production 
reported here could be further enhanced. 
Further studies are required to determine the impact of var-
ying the degree of PGS methacrylation on collagen production. 
Nevertheless, the rapid degradation rates described previously 
for PGS-M scaffolds [15], in conjunction with the improve-
ment in collagen production demonstrated in this study mean 
PGS-M has the potential to be used for the in vitro generation 
of ECM-based constructs for soft tissue engineering. 
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